1. Home
  2. ANIP vs JKS Comparison

ANIP vs JKS Comparison

Compare ANIP & JKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • JKS
  • Stock Information
  • Founded
  • ANIP 2001
  • JKS 2006
  • Country
  • ANIP United States
  • JKS China
  • Employees
  • ANIP N/A
  • JKS N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • JKS Semiconductors
  • Sector
  • ANIP Health Care
  • JKS Technology
  • Exchange
  • ANIP Nasdaq
  • JKS Nasdaq
  • Market Cap
  • ANIP 1.2B
  • JKS N/A
  • IPO Year
  • ANIP N/A
  • JKS 2010
  • Fundamental
  • Price
  • ANIP $68.02
  • JKS $18.20
  • Analyst Decision
  • ANIP Strong Buy
  • JKS Hold
  • Analyst Count
  • ANIP 8
  • JKS 5
  • Target Price
  • ANIP $79.75
  • JKS $27.19
  • AVG Volume (30 Days)
  • ANIP 361.8K
  • JKS 865.3K
  • Earning Date
  • ANIP 05-09-2025
  • JKS 03-26-2025
  • Dividend Yield
  • ANIP N/A
  • JKS 15.99%
  • EPS Growth
  • ANIP N/A
  • JKS N/A
  • EPS
  • ANIP N/A
  • JKS N/A
  • Revenue
  • ANIP $614,376,000.00
  • JKS $12,639,407,856.00
  • Revenue This Year
  • ANIP $27.62
  • JKS N/A
  • Revenue Next Year
  • ANIP $7.71
  • JKS $17.25
  • P/E Ratio
  • ANIP N/A
  • JKS $125.24
  • Revenue Growth
  • ANIP 26.20
  • JKS N/A
  • 52 Week Low
  • ANIP $52.50
  • JKS $16.70
  • 52 Week High
  • ANIP $70.00
  • JKS $37.36
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 66.14
  • JKS 30.80
  • Support Level
  • ANIP $65.28
  • JKS $20.52
  • Resistance Level
  • ANIP $69.33
  • JKS $23.21
  • Average True Range (ATR)
  • ANIP 2.32
  • JKS 1.28
  • MACD
  • ANIP 0.29
  • JKS -0.42
  • Stochastic Oscillator
  • ANIP 83.54
  • JKS 5.94

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: